Meta Atomic Deal Spurs Tactical Buy Rating for Centrus Energy
Centrus Energy's enrichment capacity is framed as a critical bottleneck for next-generation nuclear reactors after Meta's atomic deal, positioning LEU as a strategic fuel supplier. The article labels LEU a tactical buy despite its high valuation and share-price volatility, emphasizing market pricing of supply-chain security and future optionality.
1. Strategic Bottleneck in U.S. Nuclear Fuel Supply
Centrus Energy (LEU) controls roughly 30% of U.S. commercial uranium enrichment capacity, making it a critical gatekeeper for next-generation reactors. Its flagship American Centrifuge Plant in Piketon, Ohio, recently ramped to 20 million separative work units (SWU) per year, up from 5 million SWU last year, following a $75 million infusion of DOE funding. This capacity expansion positions Centrus as a linchpin in U.S. efforts to reduce reliance on Russian enrichment services and meet projected reactor fuel demand growth of 8% annually through 2030.
2. Tactical Buy After Meta’s Atomic Deal
The recent partnership between Meta and a consortium of nuclear fuel suppliers highlights Centrus’s role in securing long-term off-take agreements. In December, LEU signed a five-year, 15 million SWU deal valued at $450 million, with volume ramping from 1 million SWU in year one to 4 million SWU by year five. Despite trading at a forward price-to-earnings multiple of 25x—above the 10-year sector average of 18x—investors are paying a premium for supply chain security and de-risked contract backlog, rather than near-term GAAP earnings.
3. Volatility and Government Backing
Share price volatility of ±12% over the past six months underscores market concerns around project execution and permitting. However, Centrus has secured $150 million in additional U.S. Department of Energy support for R&D on advanced centrifuge modules, de-risking its 2028 target to reach 50 million SWU capacity. Management forecasts this scale-up could generate $600 million in annual revenues by 2029, with operating margins rising from 20% to 28%, as fixed costs are spread over a larger output.
4. Long-Term Optionality Through Advanced Technologies
Beyond current enrichment operations, Centrus holds a 40% stake in a joint venture to develop high-assay, low-enriched uranium (HALEU) fuel for small modular reactors (SMRs). The JV’s pilot line is expected online in 2025, with first commercial deliveries slated for 2027. Analysts estimate a potential $1.5 billion addressable market for HALEU by 2035, in which Centrus could capture up to 25% share owing to its first-mover advantage and existing DOE relationships.